10-Q: DLH Holdings Q3 Revenue, Profit Decline Amid Contract Shifts

DLH Holdings Corp. reported a significant decline in revenue and net income for the third quarter and first nine months of fiscal year 2025, primarily due to the conversion of key government contracts to small business contractors.

Summary

• Revenue for the three months ended June 30, 2025, decreased by $17.4 million (17.2%) to $83.3 million from $100.7 million in the prior year.
• Net income for the three months ended June 30, 2025, fell by $0.85 million (74.6%) to $0.289 million from $1.139 million in the prior year.
• For the nine months ended June 30, 2025, revenue decreased by $36.2 million (12.1%) to $263.3 million from $299.6 million.
• Net income for the nine months ended June 30, 2025, decreased by $2.82 million (55.3%) to $2.281 million from $5.102 million.
• Diluted earnings per share for the three months decreased from $0.08 to $0.02, and for the nine months from $0.35 to $0.16.
• Backlog decreased by $135 million (19.6%) to $555.3 million at June 30, 2025, from $690.3 million at September 30, 2024.
• Funded backlog saw a sharper decline of $62.8 million (40.5%) to $92.3 million from $155.1 million.
• The decline in revenue and net income is primarily attributed to the conversion of certain Department of Veterans Affairs (VA) and Department of Defense (DoD) contracts to small business contractors.

Sentiment

Score: 3

Explanation: The company experienced significant declines in revenue, net income, and backlog, primarily due to contract conversions driven by government set-aside policies. While management is in compliance with debt covenants and believes liquidity is sufficient, the substantial reduction in core financial metrics and future revenue visibility indicates a challenging period.

Positives

• Successfully amended credit facility in November 2024, modifying financial covenants and reducing the revolving line of credit amount.
• Maintained compliance with all loan covenants and restrictions as of June 30, 2025.
• Prepaid term debt, contributing to a decrease in interest expense by $0.6 million for the quarter and $1.4 million for the nine months.
• Utilized an interest rate swap with a notional amount of $74.0 million, which decreased interest expense by approximately $0.2 million for the nine months ended June 30, 2025.
• Goodwill was assessed and determined not to be impaired, despite a triggering event due to a decrease in share price.
• Management believes current cash flow and liquidity sources are sufficient to support operations for the next twelve months.

Negatives

• Significant revenue decline of 17.2% for the quarter and 12.1% for the nine months, primarily due to contract conversions to small business contractors.
• Net income decreased substantially by 74.6% for the quarter and 55.3% for the nine months.
• Diluted EPS decreased from $0.08 to $0.02 for the quarter and from $0.35 to $0.16 for the nine months.
• Total backlog decreased by 19.6% and funded backlog by 40.5%, indicating reduced future revenue visibility.
• The VA's Consolidated Mail Outpatient Pharmacy (CMOP) program contracts are transitioning to Service-Disabled Veteran Owned Small Business (SDVOSB) prime contractors, leading to DLH ceasing prime operations at some locations (e.g., Leavenworth, Kansas by August 31, 2025).
• General and administrative costs increased as a percentage of revenue to 9.4% from 9.0% for the three months ended June 30, 2025, primarily due to incremental business development costs.

Risks

• Failure to achieve anticipated benefits from future acquisitions.
• Diversion of management's attention and challenges of managing larger, more widespread operations.
• Inability to retain employees and customers.
• Risks associated with contract awards, re-competes, and competition for new business.
• Challenges in managing increased debt obligations and compliance with bank financial covenants.
• Changes in client budgetary priorities.
• Government contract procurement risks, including bid and award protests, small business set-asides, loss of work due to organizational conflicts of interest, and termination risks.
• Impact of inflation and higher interest rates on operations.
• Potential material adverse effect on goodwill valuation in future periods if a major contract is not renewed or business conditions substantially change.
• Dependence on continuation of relationships with major U.S. Federal government customers (HHS, VA, DoD).
• Material adverse effect if unable to continue relationships with major customers, lose material current contracts, or if services provided are materially reduced.
• Effect of federal contractual set-aside laws and regulations (e.g., VA's Rule of Two) may limit ability to compete for prime contractor positions on recompetes or targeted growth programs.
• Changing priorities of new administrations may adversely impact results and be difficult to predict.

Future Outlook

The company expects to continue aligning its capabilities with well-funded federal budget priorities for fiscal year 2026 to win new business. However, the impact of federal contractual set-aside laws, particularly the VA's Rule of Two, may limit the company's ability to compete as a prime contractor on certain programs. The company anticipates continuing to perform a significant volume of business as a subcontractor should awards for locations where they submitted proposals be offered to a partner. The company will provide further updates on the progression of these solicitations in future filings.

Management Comments

• We believe we are advantageously positioned within our markets through a number of features including, but not limited to: highly credentialed workforce; predominantly performing as the prime contractor; strong past performance record across our government contracts; and strong bipartisan support for our key contracts.
• We have invested in leading credentials and capabilities that we expect will deliver value to our customers.
• Management's assessment was that the market capitalization at the end of the 3rd quarter was not indicative of the Company's fair value.
• Management will continue to evaluate market conditions and perform qualitative interim assessments to determine if a triggering event has occurred.
• We believe that our current investment and financing obligations are adequately covered by cash generated from profitable operations and that planned operating cash flow should be sufficient to support our operations for twelve months from the date of issuance of these consolidated financial statements.

Industry Context

The U.S. federal government contracting industry is subject to significant budgetary shifts and policy changes, such as the VA's Rule of Two, which prioritizes Service-Disabled Veteran Owned Small Businesses (SDVOSBs). This filing highlights how such policies directly impact established contractors like DLH, leading to contract conversions and a shift from prime to subcontractor roles. The emphasis on digital transformation, cyber security, and science R&D aligns with ongoing federal modernization and health initiatives, indicating areas of continued investment despite broader budgetary pressures.

Comparison to Industry Standards

• The shift of VA CMOP contracts to SDVOSBs is a direct consequence of the VA's 'Rule of Two' policy, which mandates preference for SDVOSBs when at least two capable businesses are identified. This is a specific regulatory trend impacting large, non-SDVOSB prime contractors in this sector.
• The company's strategy to continue as a subcontractor on these transitioned contracts is a common industry practice for larger firms to retain some revenue and operational involvement when prime roles are restricted by set-aside policies.
• The decline in backlog and revenue due to contract re-competes and set-asides is a known risk in the government contracting sector, where contract awards are highly competitive and subject to policy changes.

Legal Proceedings

• The company is subject to various claims and legal actions in the ordinary course of business, including professional liability, employment-relations issues, workers compensation, tax, payroll and employee-related matters, other commercial disputes, and governmental inquiries/investigations.
• The company is not aware of any pending or threatened litigation that it believes is reasonably likely to have a material adverse effect on its results of operations, financial position, or cash flows.

Related Party Transactions

• No significant related party transactions occurred for the nine months ended June 30, 2025 and 2024 that require disclosure.

Stakeholder Impact

• Shareholders: Negative impact due to significant decline in net income and diluted EPS, and reduced backlog, which could affect future share price performance.
• Employees: Potential impact on employees at locations where prime contracts are transitioning, such as the Leavenworth, Kansas CMOP location where operations are expected to cease. However, the company expects to continue as a subcontractor, which might mitigate some job losses.
• Customers (U.S. Federal Government): Continued service provision, albeit with transitions to new prime contractors for some programs, ensuring continuity of essential services.
• Creditors: Positive impact from the company's compliance with all loan covenants and proactive debt prepayment, indicating sound financial management despite revenue challenges.

Next Steps

• Continue providing pharmacy and logistics services at five remaining VA CMOP locations through October 2025, pending new bridge contract awards.
• Provide additional updates on the progression of VA CMOP solicitations in regular quarterly and annual filings.
• Continue providing monitoring and evaluation services for the HHS Head Start program through October 2025, pending completion of the customer's procurement process.
• Evaluate the impacts of ASU 2023-09 (Income Tax Disclosures) for adoption in the Annual Report on Form 10-K for the fiscal year ending September 30, 2026.
• Evaluate the impacts of the SEC's final rule on climate-related disclosures for annual reports beginning with the year ending December 31, 2027.
• Evaluate the impacts of ASU 2024-03 (Expense Disaggregation Disclosures) for adoption in annual reporting periods beginning after December 15, 2026.
• Management will continue to evaluate market conditions and perform qualitative interim assessments for goodwill impairment.

Key Dates

Recommendation

The company faces significant headwinds with substantial declines in revenue, net income, and backlog, primarily driven by the loss of prime contractor status on key government contracts due to set-aside policies. While management is actively managing debt and maintaining compliance, the fundamental business performance metrics are deteriorating. The shift to a subcontractor role, while mitigating some losses, suggests a reduction in overall contract value and control. Given the current financial trajectory and the ongoing impact of government procurement policies, a seasoned investor would likely view this as a period of significant uncertainty and declining profitability, warranting a 'sell' recommendation.

Keywords

Government contracting, Federal health, Digital transformation, Cyber security, Science research, Systems engineering, Department of Veterans Affairs, Department of Health and Human Services, Department of Defense, SEC filing, 10-Q, Financial results, Backlog, Debt, Contract transitions